PharmaShots | Incisive News in 3 Shots

Subscribe Now

61mg

Pfizer's Vyndaqel (tafamidis- 61mg) Receives EC's Approval as the First Therapy to Treat Transthyretin Amyloid Cardiomyopathy in the EU

Pfizer's Vyndaqel (tafamidis- 61mg) Receives EC's Approval as the First Therapy to Treat Transthyretin Amyloid Cardiomyopathy in t...

February 18, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us